Fabiana Ganz

Baar, ZG, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Cracking the code of therapeutic failure in inflammatory rheumatic diseases: collaborative pathways bridging academia, industry, and patient-centric innovation.

Cracking the code of therapeutic failure in inflammatory rheumatic diseases: collaborative pathways bridging academia, industry, and patient-centric innovation.

Journal: Annals of the rheumatic diseases

Published: November 11, 2025

Achieving inactive disease state in men and women with axial spondyloarthritis: results from a multi-country prospective observational study.

Achieving inactive disease state in men and women with axial spondyloarthritis: results from a multi-country prospective observational study.

Journal: Rheumatology (Oxford, England)

Published: May 02, 2024

Radiographic Progression in Sacroiliac Joints in Patients With Axial Spondyloarthritis: Results From a Five-Year International Observational Study.

Radiographic Progression in Sacroiliac Joints in Patients With Axial Spondyloarthritis: Results From a Five-Year International Observational Study.

Journal: ACR open rheumatology

Published: May 31, 2023

Effect of Upadacitinib on Quality of Life and Work Productivity in Active Non-radiographic Axial Spondyloarthritis: Results From Randomized Phase 3 Trial SELECT-AXIS 2.

Effect of Upadacitinib on Quality of Life and Work Productivity in Active Non-radiographic Axial Spondyloarthritis: Results From Randomized Phase 3 Trial SELECT-AXIS 2.

Journal: Rheumatology and therapy

Published: February 08, 2023

Efficacy and safety of upadacitinib in patients with active psoriatic arthritis and axial involvement: results from two phase 3 studies.

Efficacy and safety of upadacitinib in patients with active psoriatic arthritis and axial involvement: results from two phase 3 studies.

Journal: Arthritis research & therapy

Published: December 16, 2022

Effect of Upadacitinib on Disease Activity, Pain, Fatigue, Function, Health-Related Quality of Life and Work Productivity for Biologic Refractory Ankylosing Spondylitis.

Effect of Upadacitinib on Disease Activity, Pain, Fatigue, Function, Health-Related Quality of Life and Work Productivity for Biologic Refractory Ankylosing Spondylitis.

Journal: Rheumatology and therapy

Published: November 07, 2022

Characteristics of patients with axial spondyloarthritis by geographic regions: PROOF multicountry observational study baseline results.

Characteristics of patients with axial spondyloarthritis by geographic regions: PROOF multicountry observational study baseline results.

Journal: Rheumatology (Oxford, England)

Published: June 10, 2021

Site-specific resolution of enthesitis in patients with axial spondyloarthritis treated with tumor necrosis factor inhibitors.

Site-specific resolution of enthesitis in patients with axial spondyloarthritis treated with tumor necrosis factor inhibitors.

Journal: Arthritis research & therapy

Published: November 19, 2020

LOOP, a cross-sectional, observational study investigating the clinical specialty setting as a determinant of disease management in psoriatic arthritis: Subgroup analysis results from Japan.

LOOP, a cross-sectional, observational study investigating the clinical specialty setting as a determinant of disease management in psoriatic arthritis: Subgroup analysis results from Japan.

Journal: PloS one

Published: January 22, 2020

Association between clinical specialty setting and disease management in patients with psoriatic arthritis: results from LOOP, a cross-sectional, multi-country, observational study.

Association between clinical specialty setting and disease management in patients with psoriatic arthritis: results from LOOP, a cross-sectional, multi-country, observational study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: May 25, 2019

Inhibition of radiographic progression in psoriatic arthritis by adalimumab independent of the control of clinical disease activity.

Inhibition of radiographic progression in psoriatic arthritis by adalimumab independent of the control of clinical disease activity.

Journal: Rheumatology (Oxford, England)

Published: July 31, 2018

Disease activity dynamics in rheumatoid arthritis: patients' self-assessment of disease activity via WebApp.

Disease activity dynamics in rheumatoid arthritis: patients' self-assessment of disease activity via WebApp.

Journal: Rheumatology (Oxford, England)

Published: August 29, 2016

Showing 1-12 of 12

Last Updated: 09/26/2026